SYNOVUS FINANCIAL CORP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 283 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 6.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
SYNOVUS FINANCIAL CORP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$3,000
-66.7%
23
-80.8%
0.00%
Q1 2020$9,000
+350.0%
120
+421.7%
0.00%
Q4 2019$2,0000.0%230.0%0.00%
Q3 2019$2,000
-33.3%
230.0%0.00%
Q2 2019$3,0000.0%230.0%0.00%
Q1 2019$3,0000.0%230.0%0.00%
Q4 2018$3,000
-50.0%
230.0%0.00%
Q3 2018$6,000230.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders